Table 1.
Main clinicopathological features of odontogenic lesions
| Clinicopathological data | AMB | UA | AC | A E/P | OKC | CEOT | Malignant OT | Total cases |
|---|---|---|---|---|---|---|---|---|
| Number of patients | 26 | 14 | 10 | 5 | 10 | 3 | 7 | 46 |
| Number of lesions | 48 | 24 | 17 | 7 | 19 | 4 | 10 | 81 |
| Mean age | 49.2 ± 18.4 | 40.0 ± 17.4 | 57.6 ± 13.6 | 64.0 ± 11.1 | 38.2 ± 17.9 | 31.0 ± 20.0 | 64.5 ± 19.9 | 47.6 ± 20.1 |
| Gendera | ||||||||
| Male | 18 | 10 | 7 | 4 | 8 | 1 | 5 | 32 |
| Female | 8 | 4 | 3 | 1 | 2 | 2 | 2 | 14 |
| Site | ||||||||
| Maxilla | 15 | 7 | 5 | 4 | 9 | 3 | 5 | 49 |
| Mandible | 33 | 17 | 12 | 3 | 10 | 1 | 5 | 32 |
| Size/cm | 3.1 ± 1.8 | 3.6 ± 2.1 | 3.0 ± 1.6 | 1.5 ± 0.7 | 2.4 ± 0.8 | 3.1 ± 1.9 | 4.3 ± 1.1 | 4.5 ± 1,6 |
| Primitive | 27 | 15 | 9 | 3 | 11 | 2 | 6 | 46 |
| Recurrence | 21 | 9 | 8 | 4 | 8 | 2 | 4 | 35 |
| DFS time/months | 51.1 ± 41.5 | 41.4 ± 36.6 | 41.0 ± 31.4 | 70.8 ± 9.8 | 47.0 ± 22.3 | 23.5 ± 16.3 | 53.7 ± 37.6 | 48.8 ± 36.2 |
AMB ameloblastoma, UA unicystic ameloblastoma, AC conventional ameloblastoma, A E/P extraosseous/peripheral ameloblastoma, OKC odontogenic keratocyst, CEOT calcifying epithelial odontogenic tumor, OT odontogenic tumor, DFS disease-free survival
aThe gender distribution is referred to the number of patients